Global Intravenous Equipment Market to Reach USD 35.27 Billion by 2035

The global intravenous equipment market has witnessed steady growth in recent years, fueled by the rising need for efficient drug delivery systems in hospitals, clinics, and home care settings. The global intravenous (IV) equipment market was valued at US$ 18,774 million in 2024 and has been forecasted to expand at a noteworthy CAGR of 5.9% to end up at US$ 35,270 million by 2035.. This growth is attributed to an aging population, increasing surgical procedures, and the rising incidence of conditions such as diabetes, cancer, and cardiovascular diseases, which often require IV therapy.

IV equipment is indispensable in various medical applications, including chemotherapy, antibiotic administration, and fluid management during surgeries. The market is segmented by product type, end-user, and region, with key products including IV catheters, infusion pumps, and administration sets. Hospitals remain the largest end-users, but home healthcare and ambulatory care centers are emerging as significant growth areas due to the shift toward outpatient care and patient-centric treatment models.

For More Insights into the Market, Request a Sample of this Report:https://www.factmr.com/connectus/sample?flag=S&rep_id=7710

Key Drivers of Market Growth

Rising Prevalence of Chronic Diseases
Chronic diseases such as cancer, diabetes, and kidney disorders are on the rise globally, necessitating long-term IV therapy for treatment and management. For instance, chemotherapy for cancer patients and dialysis for kidney failure patients rely heavily on IV equipment. The World Health Organization estimates that chronic diseases account for 60% of global deaths, underscoring the need for reliable IV solutions to manage these conditions effectively.

Technological Advancements
Innovations in IV equipment have significantly improved patient outcomes and safety. Smart infusion pumps with features like dose error reduction systems (DERS) and wireless connectivity are reducing medication errors and enhancing treatment precision. Similarly, needleless connectors and antimicrobial-coated catheters are minimizing infection risks, a critical concern in IV therapy. These advancements are driving demand for next-generation IV equipment, particularly in developed markets.

Aging Population
The global aging population is a major driver of the IV equipment market. Elderly individuals are more likely to require medical interventions involving IV therapy, such as hydration, nutrition, and medication administration. By 2030, the United Nations projects that the global population aged 60 and above will reach 1.4 billion, further increasing the demand for IV equipment in both acute and long-term care settings.

Expansion of Home Healthcare
The shift toward home-based care is transforming the IV equipment market. Patients with chronic conditions or those recovering from surgeries increasingly prefer receiving treatment at home, driving demand for portable and user-friendly IV devices. Home infusion therapy, supported by compact infusion pumps and disposable IV sets, is gaining traction, particularly in North America and Europe.

Challenges Facing the Market

Despite its growth potential, the IV equipment market faces several challenges. One significant issue is the high cost of advanced IV devices, such as smart infusion pumps, which can limit adoption in low- and middle-income countries. Additionally, the risk of catheter-related bloodstream infections (CRBSIs) remains a concern, prompting stricter regulations and the need for continuous innovation in infection prevention.

Supply chain disruptions, as seen during the COVID-19 pandemic, have also exposed vulnerabilities in the IV equipment market. Shortages of critical components and raw materials impacted production, highlighting the need for diversified supply chains and localized manufacturing. Furthermore, reimbursement challenges in some regions can hinder market growth, as healthcare providers may struggle to justify the costs of advanced IV systems.

Regional Insights

North America

North America dominates the IV equipment market, accounting for over 40% of the global share. This is driven by a well-established healthcare infrastructure, high adoption of advanced technologies, and favorable reimbursement policies. The United States, in particular, is a key market due to its large aging population and high prevalence of chronic diseases.

Europe

Europe is the second-largest market, with countries like Germany, France, and the UK leading in adoption. The region benefits from strong government support for healthcare and a growing focus on infection control measures, such as antimicrobial catheters. The rise of home healthcare in Europe is also contributing to market expansion.

Asia-Pacific

The Asia-Pacific region is expected to witness the fastest growth, driven by increasing healthcare investments, improving infrastructure, and a rising patient population. Countries like China and India are key contributors, with growing demand for affordable IV equipment in both urban and rural healthcare settings.

Rest of the World

Latin America, the Middle East, and Africa represent smaller but emerging markets. While challenges like limited healthcare access and budget constraints persist, increasing foreign investments and government initiatives are fostering growth in these regions.

Future Outlook

The IV equipment market is poised for continued growth, with several trends shaping its future. The integration of artificial intelligence (AI) and Internet of Things (IoT) technologies into IV devices is expected to enhance monitoring and reduce human errors. For example, AI-powered infusion pumps can predict potential issues and alert healthcare providers in real-time. Additionally, the development of eco-friendly and disposable IV products is gaining attention as sustainability becomes a priority in healthcare.

The growing emphasis on patient safety will drive demand for advanced securement devices and infection-resistant materials. Moreover, the expansion of telemedicine and remote patient monitoring will further support the adoption of home-based IV therapy, creating opportunities for manufacturers to develop user-friendly and cost-effective solutions.

Get Customization on this Report for Specific Research Solutions-https://www.factmr.com/connectus/sample?flag=S&rep_id=7710

Competitive Landscape

The IV equipment market is highly competitive, with key players including Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Baxter International, and ICU Medical. These companies are focusing on product innovation, strategic partnerships, and mergers to strengthen their market position. For instance, BD's acquisition of Velano Vascular has expanded its portfolio of needle-free blood collection and IV delivery systems.

Conclusion

The intravenous equipment market is a dynamic and rapidly evolving sector, driven by technological advancements, demographic shifts, and the increasing demand for efficient healthcare solutions. While challenges such as high costs and infection risks remain, the market's growth trajectory is strong, supported by innovations and expanding applications in home and ambulatory care. As healthcare systems worldwide continue to prioritize patient safety and accessibility, the IV equipment market is set to play a pivotal role in shaping the future of medical care.

Explore More Related Studies Published by Fact.MR Research:

Polybutylene Adipate Terephthalate (PBAT) Industry Analysis in East Asia

https://www.factmr.com/report/polybutylene-adipate-terephthalate-industry-analysis-in-east-asia

Prostatic Catheter Market

https://www.factmr.com/report/prostatic-catheter-market

Thermoplastic Vulcanizate Industry Analysis in Latin America

https://www.factmr.com/report/thermoplastic-vulcanizate-industry-analysis-in-latin-america

Heat Meter Market

https://www.factmr.com/report/heat-meter-market

Nanocrystalline Soft Magnetic Material Industry Analysis in North America

https://www.factmr.com/report/nanocrystalline-soft-magnetic-material-industry-analysis-in-north-america

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR:

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.